F.D.A. Panel Endorses Pfizer-BioNTech Shots for Young Children

A Food and Drug Administration advisory committee voted to recommend a pediatric dose of the Pfizer-BioNTech coronavirus vaccine for children between the ages of 5 and 11.A Food and Drug Administration advisory committee voted to recommend a pediatric dose of the Pfizer-BioNTech coronavirus vaccine for children between the ages of 5 and 11.Vaccination and Immunization, Youth, Coronavirus (2019-nCoV), Food and Drug Administration, Pfizer IncRead More

Leave a Reply

Your email address will not be published.